Manuel Saldivia
@ampliconX
Followers
159
Following
3K
Media
135
Statuses
484
Drug discovery. For external use only.
San Francisco, CA
Joined July 2010
Happy to see our work released today. Thanks @Mottram_group and @NovartisScience for the opportunity. Trypanosomatids never ceases to amaze me!š.
7
9
40
Passionate about infectious diseases and brain organoids? We are hiring a Postdoc in our team!
0
3
4
RT @Novartis: Glad we got your attention! Now letās get seriousāEarly detection can be a game changer in the fight against breast cancer. Kā¦.
0
5
0
I am grateful for the fantastic opportunity to visit York in December after six years. Thank you, @Mottram_group , for being a fantastic host.
0
0
7
RT @jayanta_amr: ACS Infectious Diseases is pleased to bring a Virtual Special Issue on "One Health and Vector Borne Parasitic Diseases", lā¦.
0
5
0
Kudos to the Novartis Global Health team for their dedicated efforts in battling Cryptosporidiosis! š.
Out now: Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat pediatric enteric cryptosporidiosis @NovartisScience
0
0
1
RT @fidocklab: Congrats to Lab member @JohnOkombo5 on publishing "Towards next-generation treatment options to combat Plasmodium falciparumā¦.
0
16
0
RT @striepenlab: It appears #NIAID will shutter the genome data base we all use daily. This strikes me as a significant mistake that may weā¦.
0
131
0
Listening to @Filipa_Ferr talk about her amazing work is the perfect way to kickstart my motivation post-holidays!.
0
0
1
I am celebrating my birthday with my family for the first time in 16 years!
4
0
19
RT @NovartisNews: Novartis and @MedsforMalaria announce positive data from the trial of a treatment for the tiniest babies with #malaria. Tā¦.
0
4
0
Exciting news of LXE408's progress for VL #HopeForLeishmaniasis.
š£ New #HopeForLeishmaniasis! Together with our partners, weāve started a Phase II clinical trial for a potential all-oral medicine to treat visceral #leishmaniasis at the University of Gondar in Ethiopia. Read press release ā”ļø #beatNTDs š§µ.
0
2
7
RT @ACSBioMed: š¢ Call for Papers š¢This new Special Issue from ACS Infectious Diseases will showcase the latest tuberculosis biology and medā¦.
0
3
0
Thrilled to join the ACS Infectious Diseases Early Career Board. @ACSBioMed #ACSInfectiousDiseases
3
1
9
RT @TrendsParasitol: Drs Manuel Saldivia, Ana Lima & @Mottram_group highlight a promising pipeline of preclinical drug candidates for #viscā¦.
0
13
0
I had a blast today sharing my experience in drug discovery at the University of Berkeley. Thanks @Filipa_Ferr for the opportunity!
0
1
12
RT @drughuntersite: Recently, Novartis disclosed a new class of brain-penetrant, covalent agents against kinetoplastid parasites in Scienceā¦.
0
14
0
Collaboration between academia and industry is critical for bridging the gap between theory and application. It fosters innovation and translates knowledge into solutions that benefit patients. #research #innovation #healthcare
nature.com
Nature Reviews Drug Discovery - Discover the worldās best science and medicine | Nature.com
0
13
42
A new class of antiparasitic drugs - free access
science.org
A class of cyanotriazole drugs that provide fast-acting trypanosomatid-specific topoisomerase II inhibitors was identified.
0
0
2